C
Pitched
Biotech / MedTech / DeepTech
pre seed
CardioMol
Structure-based in-silico drug design and computational lead optimization platforms
About
CardioMol is an advanced biotechnology startup providing end-to-end digital drug discovery workflows for pharmaceutical research. Utilizing a high-performance in-silico drug design environment, the platform accelerates candidate testing from initial target identification through to optimized chemical leads. By simulating drug interactions computationally, it predicts active molecule efficacy, structural selectivity, and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiles.
Achievements & Progress
No public achievements or progress updates yet.
